INJ.X

Injective

Altcoins like VET, OP, INJ, XTZ, and UNI are showing consolidation patterns indicative of potential multi-year breakouts. Technological updates, governance improvements, and layer-2 adoption contribute to long-term stability and growth. Trading volumes and on-chain activity sugge...

Cryptocurrency is evolving, and retirement plans are changing beyond Bitcoin and Ethereum. Analysts now recommend investing in smaller-capacity altcoins that are still in the early stages of development. In addition to their infrastructural relevance, these tokens may offer prosp...

Pineapple Financial’s $100M Digital Asset Treasury strategy on Injective drives institutional momentum as PAPL volumes surge and INJ consolidates near $14, eyeing a breakout above $14.50. <p>The post Blockchain Treasuries Expand: Injective Gains Momentum While INJ first appeared ...

Injective has confirmed that Nasdaq-listed fintech firm Pineapple Financial has officially closed its $100 million fundraise to buy and stake native INJ. The development has sparked excitement among cryptocurrency enthusiasts, with INJ gaining over 5% in the past 24 hours. Pineapple Financial will cooperate with institutional-level asset managers to begin accumulating Injective tokens this month. The program includes buying Injective assets in the upcoming weeks until Pineapple exhausts the entire $100 million. The announcement highlighted: Purchases will be publicly revealed and will be executed by institutional asset managers in the open market, with the accumulation program expected to continue over the coming weeks until the full $100 million worth of INJ is acquired. Injective 🥷 @injective · Follow Pineapple Financial has officially completed its $100 Million capital raise to purchase $INJ .Starting this month, Pineapple will accumulate $INJ tokens and stake them with the aim of generating an estimated 12% annual yield, placing its strategy well ahead of major digital Watch on Twitter View replies 7:29 PM · Sep 8, 2025 3 Reply Copy link Read more on Twitter At prevailing market prices, the $100 million investment would mean acquiring around 7% of INJ’s circulating supply, making Pineapple among the top Injective holders. Staking approach with long-term goals Indeed, the blockchain space has witnessed increased appetite for crypto treasuries in the past months. While most corporates spread associated risks across several assets, Pineapple plans to go all-in on INJ. The company will stake its investment to generate a roughly 12% yearly yield. That strategy would put Pineapple Financial well ahead of many renowned crypto treasury approaches. Besides targeting more yields, the focused approach aligns Pineapple’s credibility with Injective’s growth vision. The company remains dedicated to making INJ the central asset for its monetary strategies in the coming years. Injective’s tokenomics spark interest Meanwhile, such narratives indicate unwavering confidence in the altcoin’s long-term potential. Besides futuristic developments in the AI field , Injective’s tokenomics likely fueled Pineapple’s move. Unlike most cryptocurrencies, INJ doesn’t have impending token unlocks for private investors. That eliminates dilution risks and unexpected volatility in the future. All Injective tokens are already in circulation, allowing Pineapple Financial to build its crypto portfolio without lingering concerns. Moreover, Injective uses its on-chain revenue to burn tokens. It has removed over 6.7 million INJ tokens from supply. Pineapple’s continuous accumulation and staking amidst the blockchain’s pursuit for scarcity sets the stage for impressive growth for the network and its native token. INJ price outlook Injective painted its 24-hour chart green after the announcement, gaining 5.6% from $13.04 to $13.77 intraday. The alt has retraced from the peaks to $13.62 at press time, with the recovering trading volume hinting at continued surges. Chart by Coinmarketcap Bullish technical indicators such as the MACD and the RSI support extended rallies for INJ in the near-term, with buyers targeting resistance around $15. Meanwhile, prevailing broader sentiments will influence INJ’s short-term performance. However, the emerging institutional interest positions the token for significant rallies amid market recoveries. Other companies might follow Pineapple’s move to invest in Injective, considering the alt’s lucrative tokenomics . The post Injective price jumps 5% as Pineapple Financial commits $100M to INJ staking appeared first on Invezz

Crypto analyst Crypto Patel has forecasted a significant price surge for Injective ($INJ) in the current bull market. The analyst believes the cryptocurrency is on the cusp of a breakout, driven by a clear Elliott Wave pattern forming on the chart. According to Patel, the complet...

Altcoins are entering the optimism phase, often a precursor to widespread accumulation before FOMO-driven rallies. HBAR, LINK, RENDER, ONDO, and INJ exhibit exceptional qualities, from unmatched efficiency to groundbreaking innovation. Analysts highlight these tokens as resilient...

Injective Protocol trades near $13 with buyers defending $12 support, while repeated resistance at $15–$16 forms a key supply barrier. Open interest is rising steadily as traders prepare for volatility, with declining trading volume suggesting momentum will return on breakout con...

Injective Protocol is consolidating above ascending triangle support with bullish divergence, signaling potential breakout conditions. Price trades near $12.53 with a short-term range between $12.30 support and $13.00 resistance. Market cap stands at $1.25B with almost full suppl...

INJ trades above support in an ascending triangle pattern, with resistance at $15.70 and bullish divergence on daily charts. Weekly structure shows a falling wedge forming since early 2024, with a bounce from $10.13 suggesting a potential mid-term breakout setup. Pineapple Financ...